🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
179 results for “Fresenius”
MedicineActive substanceLicence holderStatus
Ondansetron Kabi 0.16 mg/ml solution for infusion
PA2059/080/002
Ondansetron hydrochloride dihydrate Fresenius Kabi Deutschland GmbH Not marketed
Ondansetron Kabi 2 mg/ml solution for injection
PA2059/048/001
Ondansetron Fresenius Kabi Deutschland GmbH Marketed
Otulfi 130 mg Concentrate for solution for infusion
EU/1/24/1863/003
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 45 mg Solution for injection
EU/1/24/1863/001
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 45 mg Solution for injection pre-filled pen
EU/1/24/1863/005
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 90 mg Solution for injection
EU/1/24/1863/002
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 90 mg Solution for injection in Pre-filled pen
EU/1/24/1863/006
Ustekinumab Fresenius Kabi Deutschland GmbH
Oxaliplatin 5 mg/ml concentrate for solution for infusion
PA2059/049/001
Oxaliplatin Fresenius Kabi Deutschland GmbH Marketed
Paclitaxel 6 mg/ml concentrate for solution for infusion
PA2059/050/001
Paclitaxel Fresenius Kabi Deutschland GmbH Marketed
Paedisol Solution for Infusion
PA2059/029/001
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium acetate trihydrate Fresenius Kabi Deutschland GmbH Not marketed
Palonosetron 250 micrograms Solution for injection
PA2059/014/001
Palonosetron hydrochloride Fresenius Kabi Deutschland GmbH Not marketed
Palonosetron 250 micrograms solution for injection in pre-filled syringe
PA2059/014/002
Palonosetron hydrochloride Fresenius Kabi Deutschland GmbH Marketed
Paracetamol 10 mg/ml solution for infusion
PA2059/015/001
Paracetamol Fresenius Kabi Deutschland GmbH Marketed
Paracetamol 10 mg/ml solution for infusion
PA2059/015/002
Paracetamol Fresenius Kabi Deutschland GmbH Not marketed
Pedismof emulsion for infusion
PA2059/087/003
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamine acid Fresenius Kabi Deutschland GmbH Not marketed
Pedismof Neonate and Infant emulsion for infusion
PA2059/087/002
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamine acid Fresenius Kabi Deutschland GmbH Not marketed
Pedismof Neonate emulsion for infusion
PA2059/087/001
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamine acid Fresenius Kabi Deutschland GmbH Not marketed
Peditrace concentrate for solution for infusion
PA2059/051/001
Zinc chloride, Copper chloride 2H2O, Manganese chloride 4H2O, Sodium selenite anhydrous, Sodium fluoride Fresenius Kabi Deutschland GmbH Marketed
Pemetrexed Fresenius Kabi 100 mg powder for concentrate for solution for infusion
EU/1/16/1115/001
Pemetrexed Fresenius Kabi Deutschland GmbH
Pemetrexed Fresenius Kabi 25 mg/ml concentrate for solution for infusion
EU/1/16/1115/003-005
Pemetrexed Fresenius Kabi Deutschland GmbH
Pemetrexed Fresenius Kabi 500 mg powder for concentrate for solution for infusion
EU/1/16/1115/002
Pemetrexed Fresenius Kabi Deutschland GmbH
Piperacillin/Tazobactam 2 g/0.25 g powder for solution for infusion
PA2059/016/001
Piperacillin, Tazobactam Fresenius Kabi Deutschland GmbH Not marketed
Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
PA2059/016/002
Piperacillin, Tazobactam Fresenius Kabi Deutschland GmbH Marketed
Potassium Chloride 0.15% w/v & Glucose 5% w/v Solution for Infusion
PA2059/053/001
Potassium chloride, Glucose monohydrate Fresenius Kabi Deutschland GmbH Marketed
Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion
PA2059/052/001
Potassium chloride, Sodium chloride Fresenius Kabi Deutschland GmbH Marketed
Potassium Chloride 0.3% w/v & Glucose 5% w/v Solution for Infusion
PA2059/053/002
Potassium chloride, Glucose monohydrate Fresenius Kabi Deutschland GmbH Marketed
Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion
PA2059/052/002
Potassium chloride, Sodium chloride Fresenius Kabi Deutschland GmbH Marketed
Potassium Chloride 15% w/v Concentrate for Solution for Infusion
PA2059/054/001
Potassium chloride Fresenius Kabi Deutschland GmbH Not marketed
Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule
PA2059/055/001
Propofol Fresenius Kabi Deutschland GmbH Not marketed
Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, vial
PA2059/055/002
Propofol Fresenius Kabi Deutschland GmbH Not marketed
Propofol 1% (10 mg/ml) emulsion for injection/infusion
PA2059/017/001
Propofol Fresenius Kabi Deutschland GmbH Marketed
Propofol 1% (10 mg/ml) emulsion for injection/infusion in pre-filled syringe
PA2059/017/004
Propofol Fresenius Kabi Deutschland GmbH Marketed
Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule
PA2059/055/003
Propofol Fresenius Kabi Deutschland GmbH Not marketed
Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial
PA2059/055/004
Propofol Fresenius Kabi Deutschland GmbH Not marketed
Propofol 2% (20 mg/ml) emulsion for injection/infusion
PA2059/017/003
Propofol Fresenius Kabi Deutschland GmbH Marketed
Propofol 2% (20 mg/ml) emulsion for injection/infusion in pre-filled syringe
PA2059/017/005
Propofol Fresenius Kabi Deutschland GmbH Not marketed
Remifentanil 1 mg powder for concentrate for solution for injection or infusion
PA2059/056/001
Remifentanil Fresenius Kabi Deutschland GmbH Not marketed
Remifentanil 2 mg powder for concentrate for solution for injection or infusion
PA2059/056/002
Remifentanil Fresenius Kabi Deutschland GmbH Not marketed
Remifentanil 5 mg powder for concentrate for solution for injection or infusion
PA2059/056/003
Remifentanil Fresenius Kabi Deutschland GmbH Not marketed
Rocuronium 10 mg/ml solution for injection/infusion
PA2059/018/001
Rocuronium bromide Fresenius Kabi Deutschland GmbH Marketed
Ropivacaine 2 mg/ml solution for injection
PA2059/021/001
Ropivacaine Hydrochloride Fresenius Kabi Deutschland GmbH Not marketed
Ropivacaine 7.5 mg/ml solution for injection
PA2059/021/002
Ropivacaine Hydrochloride Fresenius Kabi Deutschland GmbH Not marketed
SmofKabiven Central emulsion for infusion
PA2059/058/002
Soya bean oil, refined, Medium chain triglycerides, Refined soyabean oil, Fish oil, rich in omega-3 acids, L-alanine Fresenius Kabi Deutschland GmbH Marketed
SmofKabiven Electrolyte Free Central emulsion for infusion
PA2059/059/002
L-alanine, L-arginine, Glycine, L-histidine, L-isoleucine Fresenius Kabi Deutschland GmbH Marketed
SmofKabiven extra Nitrogen Electrolyte free, emulsion for infusion
PA2059/060/002
Alanine, Arginine, Glycine, Histidine, Isoleucine Fresenius Kabi Deutschland GmbH Not marketed
SmofKabiven extra Nitrogen, emulsion for infusion
PA2059/060/001
Methionine, Phenylalanine, Proline, Serine, Taurine Fresenius Kabi Deutschland GmbH Marketed
SmofKabiven Low Osmo Peripheral emulsion for infusion
PA2059/022/001
Alanine, Arginine, Glycine, Histidine, Isoleucine Fresenius Kabi Deutschland GmbH Not marketed
SmofKabiven Peripheral, emulsion for infusion
PA2059/061/002
SOYA BEAN OIL, REFINED PH. EUR., Medium chain triglycerides, Refined olive oil, Fish oil, rich in omega-3 acids, Isoleucine Fresenius Kabi Deutschland GmbH Marketed
SMOFlipid 200 mg/ml emulsion for infusion, excel bag
PA2059/062/002
Soya bean oil, Medium chain triglycerides, Refined olive oil, Fish oil, rich in omega-3 acids Fresenius Kabi Deutschland GmbH Marketed
SMOFlipid 200 mg/ml emulsion for infusion, glass bottle
PA2059/062/001
Soybean oil, Triglycerides, medium chain, Refined olive oil, Fish oil, rich in omega-3 acids Fresenius Kabi Deutschland GmbH Marketed
1 2 3 4
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.